Atlas Trials

Beacon Therapeutics

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Beacon Therapeutics

RecordFirmDate
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa (NCT07174726)Beacon Therapeutics2025-09-10
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP (NCT04850118)Beacon Therapeutics2024-03-14
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) (NCT06275620)Beacon Therapeutics2023-11-14
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) (NCT06333249)Beacon Therapeutics2021-04-13
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (NCT03316560)Beacon Therapeutics2018-04-16
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) (NCT03314207)Beacon Therapeutics2017-12-01

Track Beacon Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.